NEW YORK, NY - August 11, 2026 (NEWMEDIAWIRE) - Synbio International, Inc. (OTC: SYIN) today marks a significant milestone in its evolution. After an extended period focused on corporate restructuring, strategic partnerships, and business development, the Company is now entering commercial operations with the launch of its Healing Force™ nutraceutical division and first consumer product.

Company Begins Executing Revenue Generation Strategy through First Commercial Product Launch

The launch marks Synbio's transition from a development-stage company to an operating business. It also reflects the Company's strategy of combining near-term revenue generation through commercial wellness products with the long-term value creation potential of its AI-driven healthcare technologies.

The first product to be offered under the Healing Force™ brand will be Healing Force™ Anxiety Relief, a natural wellness formulation designed to support individuals seeking non-pharmaceutical approaches to managing everyday stress and anxiety.

Unlike pharmaceutical products, nutraceuticals can be brought to market without lengthy pre-market approval processes, allowing Synbio to commercialize developed formulations and pursue near-term revenue opportunities rapidly.

"This announcement represents much more than the launch of a single product," said Claudio Solitario, Chief Executive Officer of Synbio International. "It marks Synbio's transition into an operating company and the beginning of a strategy designed to create sustainable long-term shareholder value through multiple revenue streams.

"We are launching Healing Force™ at a time when the global nutraceuticals market is experiencing extraordinary growth. With the market expected to grow from approximately US$684 billion today to more than US$1.1 trillion by 2033, driven by increasing consumer demand for preventative healthcare and natural wellness products, we believe Synbio is entering this sector at exactly the right time.

"The Healing Force™ operations are expected to serve as a foundation for future product expansion, with additional wellness formulations currently under evaluation for potential commercialization. After years of laying the foundation, today we begin building the business.”

Building a Diversified Wellness and Healthcare Platform

Synbio is building a diversified healthcare company that combines medical technologies with science-based wellness products. By balancing near-term commercial opportunities with longer-term technology development, the Company believes it can create multiple sources of revenue and sustainable growth.

The Company continues to advance its healthcare technology initiatives, including the validation of the FacialDx Inc. facial analysis platform for mental health, while simultaneously developing wellness products. Management believes this dual-track strategy provides opportunities for both near-term revenue generation and long-term value creation.

Experienced Medical and Scientific Leadership

The Healing Force™ product line has been developed under the guidance of Dr. David Anderson, M.D. Dr. Anderson has spent decades developing, evaluating and scientifically validating nutraceuticals, wellness products and related healthcare technologies. His experience spans medical research, product development and scientific substantiation, providing Synbio with a strong scientific foundation for its expanding Healing Force™ product portfolio. He previously served as a Research Physician and Senior Research Scientist and has coordinated numerous medical and scientific research programs involving academic institutions, physicians, government agencies, and commercial organizations.

"Consumers are increasingly seeking evidence-based wellness solutions that support healthy lifestyles," said Dr. Anderson. "Our goal is to develop products grounded in scientific principles while addressing growing consumer demand for natural approaches to stress management and emotional well-being."

Capital-Efficient Commercialization Strategy

To maximize capital efficiency, Synbio plans to initially market and distribute Healing Force™ products through direct-to-consumer online channels.

Initially, Synbio will commercialize Healing Force™ through direct-to-consumer online sales supported by targeted digital marketing and e-commerce initiatives. Management believes this capital-efficient model will enable the Company to scale rapidly while preserving financial flexibility as additional products are introduced.

About Synbio International Inc.

Synbio International Inc (SYIN) is a company focused on clinically validating an AI-driven software that will screen for mental health conditions using facial analysis. Through strategic partnerships and research collaborations, Synbio aims to help develop and validate science-based solutions that improve the quality of life and empower healthcare providers. To generate early revenue while its software advances through validation, Synbio plans to launch a line of nutraceutical products sold directly to consumers online in 2026.

For inquiries, please contact:
Synbio International Inc.
info@synbiointl.com
(646) 359-4854
www.synbiointl.com

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements in this press include, among others, statements about our renegotiated settlement agreement. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans, and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our limited operating history; our dependence on third parties for many aspects of our business; general market and economic conditions; technical factors; the availability of outside capital; our receipt of revenues; legislative developments; changes in our expenditures and other uses of cash; our ability to find, recruit and retain personnel in sufficient numbers to support our growth; our ability to manage growth; and general market, economic and business conditions. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

View the original release on www.newmediawire.com

This contant was orignally distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Synbio International Commences Revenue-Generating Operations With Launch of Healing Force™ Nutraceutical Division.